Since the discovery of 'protein kinase activity' in 1954, close to 600 kinases have been discovered that play a critical role in cell physiology. In several pathological conditions, aberrant protein kinase activity leads to abnormal cell and tissue physiology. Therefore, protein kinase inhibitors are investigated as potential treatments for several diseases, including dementia, diabetes, cancer, autoimmune and cardiovascular disease. Modern 2 semiconductor technology has recently been applied to accelerate the discovery of novel protein kinase inhibitors that may become the standard of care drugs of tomorrow. Here we describe current techniques and novel applications of semiconductor technologies in protein kinase inhibitor drug discovery.
Introduction
The therapeutic need for novel and efficacious treatments remains unmet for several human diseases. In addition, even when effective treatments are available, the onset of drug resistance or the occurrence of side effects associated with prolonged drug use requires the discovery of novel drugs [1] . The acceleration of the drug discovery cycle remains a priority in several biomedical fields and will depend on the availability of new tools for drug screening in academia and industry. Protein kinase inhibitors are one of the most important target groups for drug development [2] . Nonetheless, only a small portion of human protein kinases can be effectively modulated using specific inhibitors [3] . To date, more than 400 diseases are reported to be caused either directly or indirectly by deregulation or mutation of protein kinases [4] , and over 200 protein kinase genes map to disease loci or cancer amplicons [5] . The drug development opportunities are enormous, but the rate of discovery and approval of new protein kinase-targeting drugs remains low [6, 7] . Part of the problem resides in the in vitro assays used for the primary screening of compounds that inhibit or modulate protein kinase activity.
The most common techniques used to investigate protein kinase activity are kinase assay sthat use 32 -phosphorus ( 32 P) labelling of peptides designed to mimic the kinases target sequences [8] or phosphor-specific immunodetection assays (e.g. ELISA, immunoblots or flow cytometry), which rely on antibodies selectively recognising their targets when phosphorylated [9] , or spectroscopic techniques with nanoparticles acting as markers for phosphorylation [10] . Mass spectrometry-based detection of protein phosphorylation or phosphoproteomics has also become a very important technique in protein kinase investigations [11] . Despite recent developments facilitating their use for basic research and target identification (e.g. [12] ), none of the above techniques has the high throughput necessary for primary drug screening. For drug discovery purposes, binding assays are utilised to test the ability of putative compounds to inhibit the interaction of protein kinases with their protein substrates [13] or their binding of ATP [14] . Fluorescence-based assays have also become widely used for the screening of large libraries of compounds and development of new drugs [15] . Fluorescent biosensors for protein kinase studies entail a biochemical moiety that recognizes the target kinase in its active state (e.g. a substrate or binding domain), which is coupled to a fluorescent probe and therefore transduces kinase activation into a measurable signal.
Both traditional binding or fluorescence biosensor-based assays have an important limitation: they identify molecules targeting the specific molecular event that they measure (i.e. binding to specific ligand or binding of ATP). This leads to the loss as false negatives of compounds targeting other aspects of the enzymatic reaction, which is responsible for a weak correlation between binding/fluorescence-based screenings and kinase activity assay results [16] . Screening results based on binding assays can therefore be misinterpreted and promising protein kinase inhibitors can be missed.
Similarly, drug screenings based on the detection of endpoint functional responses (e.g. cell apoptosis, proliferation or metabolic throughput), have the important limitation of identifying compounds affecting the event providing the readout signal, rather than directly binding and modulating protein kinases.
We have recently described a novel method based on the use of an electrolyte-insulator-semiconductor (EIS) for the detection of the protein phosphorylation reaction [17] [18] [19] . This methods has several advantages over existing methods, including: 1) identification of compounds interfering with different aspects of the catalytic mechanism of protein kinases (rather than just interfering with ATP-or substrate-binding); 2) detection of phosphorylation in real time and monitoring the rate of phosphorylation reactions, therefore allowing kinetics studies (rather than relying on the end-point detection of reaction products -i.e. phosphorylated substrates by 32 -P incorporation and phospho-dependent immunodetection); 3) high throughput and potential for upscaling; 4) low cost. A large number of intra/inter cellular reactions involve charge transfer or release of protons. Upon surface immobilization of substrates or enzymes, the release of protons or the minute changes in electrical charge associated with chemical reactions can therefore be measured. A commonly used pH sensitive material is silicon nitride, which in our recent studies has been employed to measure the release of protons associated with protein phosphorylation [17] [18] [19] . The surface charge of the silicon nitride can be measured by integrating it with a semiconductor in form of an ISFET or EIS sensor.
Semiconductor technology applied to biology and drug discovery
The detection mechanism of EIS is similar to the operation of ISFETs. The difference lies in the fact that the EIS is a two-terminal capacitor structure, while the ISFET has extra contacts on doped regions of the semiconductor to operate as a three-terminal transistor. The adsorption of ions on the surface of the dielectric material creates an electric field across the dielectric material, inducing changes in the underlying semiconductor. The mechanism can be explained by site binding theory, which relates the solid-liquid interface potential to local pH changes in the solution [20] . In the case of silicon nitride, at the dielectric material/solution interface, Si3N4 presents active sites in the form of neutral surface hydroxyl (SiOH) groups, which capture H + ions released by chemical reactions until thermodynamic equilibrium is established, as described by the following reaction:
SiOH ↔ SiOH H After the hydrogen ion is captured by the silicon nitride, the surface potential of the structure changes. If this structure acts as the gate of the transistor, gate to source voltage of the transistor would also change. Equation 1.1 below shows the dependence of the semiconductor surface potential ( ) on the hydrogen ion concentration:
where C1 is the accumulation capacitance due to the two dielectric layers, namely Si3N4 and SiO2 in the structure that has been used. , and , denote the electric field and thickness of each dielectric layer. inhibitors (drugs) in an effective and convenient manner [22] . Therefore, its application in the development of miniaturised drug discovery platforms is promising and deserves attention.
Protein phosphorylation on EIS Sensors
EIS sensors have become established in the biosensing community as powerful tools to detect pH changes in highly resolved temporal and spatial patterns [23, 24] . In the context of protein phosphorylation, there have been previous studies focusing on the detection of the change in substrate protein electrical charge rather than on the release of protons in the protein kinase reaction. Freeman et al. were the first to study the degree of gate surface charging detectors due to kinase activity [25] . They used an aluminium oxide gated ISFET to follow the phosphorylation of proteins. This system allowed monitoring of both phosphorylation and dephosphorylation in real-time, leading to the estimation of phosphorylation reaction kinetics. Electrochemical detection of protein kinase activity using FEDs has been demonstrated in several relevant studies using different semiconductive materials, such as silicon [26] , indium tin oxide (ITO) [27] and boron-doped diamond [28] . In other studies, different reagents were utilised to enhance the detection of the protein kinase reaction, including TiO2/silver nanoparticles [29] and Carbon nanotubes (CNTs) [30] . The same authors also demonstrated the use of gold nanoparticles combined with semiconductor technology to obtain the electrochemical detection of the enzymatic reaction catalysed by tyrosine protein kinases [31] .
In our recent work, we demonstrated that a semiconductor-based EIS can be applied to dual detection of proton release and surface charge change associated with the phosphorylation of surface-absorbed proteins [17] [18] [19] . Figure 1 shows a detection scheme for dual mode biosensing employed by Bhalla et al. [17] . In this work the authors used Si3N4-based EIS structures as well as gold-insulator-semiconductor capacitor structures for the detection of pH and electrical charge changes associated with phosphorylation of proteins, respectively. In both methods, a conventional three-electrode electrochemical setup was employed with an Ag/AgCl reference electrode immersed in the electrolyte via a salt bridge, used to apply the gate voltage, and a platinum (Pt) counter electrode. The Capacitance-Voltage (CV) charactertsics of the sensor were monitored to detect the kinase activity.
Upon kinase-mediated protein phosphorylation, each amino acid undergoing phosphorylation releases a proton that is adsorbed onto the Si3N4 surface. As a result, the threshold potential of the structure decreases and a change in potential is observed.
The longer the reaction with kinase/ATP is left to progress, the higher the Vg changes that are achieved. Our studies demonstrated the use of EIS to study phosphorylation of myelin basic protein (MBP) by PKC- in the presence of a phosphate source (ATP /ATP-S) [17] [18] [19] . The phosphorylation reaction and its inhibition could be detected, as the phosphorylation reaction was associated with significantly higher signal (37 mV) compared to the inhibited reaction (5 mV). activity, where it would be difficult to detect the phosphorylation reaction using only an EIS system, LSPR facilitates the detection of the reaction and its completion.
Conclusions and Outlook
Semiconductor EIS devices display remarkable performances in the detection of protien 
